These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 7586357

  • 1. Determination of ventricular vulnerable period and ventricular fibrillation threshold by use of T-wave shocks in patients undergoing implantation of cardioverter/defibrillators.
    Hou CJ, Chang-Sing P, Flynn E, Martinez L, Peterson J, Ottoboni LK, Liem LB, Sung RJ.
    Circulation; 1995 Nov 01; 92(9):2558-64. PubMed ID: 7586357
    [Abstract] [Full Text] [Related]

  • 2. Detection of the defibrillation threshold using the upper limit of vulnerability following defibrillator implantation.
    Kirilmaz A, Dokumaci B, Uzun M, Kilicaslan F, Dinckal MH, Yucel O, Karaca M.
    Pacing Clin Electrophysiol; 2005 Jun 01; 28(6):498-505. PubMed ID: 15955181
    [Abstract] [Full Text] [Related]

  • 3. The effect of induction method on defibrillation threshold and ventricular fibrillation cycle length.
    Zima E, Gergely M, Soós P, Gellér LA, Nemes A, Acsády G, Merkely B.
    J Cardiovasc Electrophysiol; 2006 Apr 01; 17(4):377-81. PubMed ID: 16643358
    [Abstract] [Full Text] [Related]

  • 4. Non-invasive evaluation of ventricular refractoriness and its dispersion during ventricular fibrillation in patients with implantable cardioverter defibrillator.
    Luo J, Pripp CM, Hertervig E, Kongstad O, Ljungström E, Olsson SB, Yuan S.
    BMC Cardiovasc Disord; 2004 Jun 09; 4():8. PubMed ID: 15186504
    [Abstract] [Full Text] [Related]

  • 5. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD, Doshi RN, Belott P, Birgersdotter-Green U, Behboodikhah M, Ott P, Glatter KA, Tobias S, Frumin H, Lee BK, Merillat J, Wiener I, Wang S, Grogin H, Chun S, Patrawalla R, Crandall B, Osborn JS, Weiss JP, Lappe DL, Neuman S.
    Circulation; 2007 May 08; 115(18):2382-9. PubMed ID: 17470697
    [Abstract] [Full Text] [Related]

  • 6. Upper limit of vulnerability is a good estimator of shock strength associated with 90% probability of successful defibrillation in humans with transvenous implantable cardioverter-defibrillators.
    Swerdlow CD, Ahern T, Kass RM, Davie S, Mandel WJ, Chen PS.
    J Am Coll Cardiol; 1996 Apr 08; 27(5):1112-8. PubMed ID: 8609329
    [Abstract] [Full Text] [Related]

  • 7. Influence of drive cycle length on initiation of ventricular fibrillation during implantable cardioverter defibrillator threshold testing.
    Sanghvi NK, Lelorier P, Gururaj AV, Monahan KM.
    Pacing Clin Electrophysiol; 2006 Sep 08; 29(9):926-9. PubMed ID: 16981914
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Electrocautery-induced ventricular tachycardia and fibrillation during device implantation and explantation.
    Lo R, Mitrache A, Quan W, Cohen TJ.
    J Invasive Cardiol; 2007 Jan 08; 19(1):12-5. PubMed ID: 17297178
    [Abstract] [Full Text] [Related]

  • 10. Achieving sufficient safety margins with fixed duration waveforms and the use of multiple time constants.
    Keane D, Aweh N, Hynes B, Sheahan RG, Cripps T, Bashir Y, Zaidi A, Fahy G, Lowe M, Doherty P, Kroll MK.
    Pacing Clin Electrophysiol; 2007 May 08; 30(5):596-602. PubMed ID: 17461867
    [Abstract] [Full Text] [Related]

  • 11. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ, Multicenter Automatic Defibrillator Implantation Trial II investigators.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1481-7. PubMed ID: 15464332
    [Abstract] [Full Text] [Related]

  • 12. [The T-wave shock: a new reliable method for induction of ventricular fibrillation in ICD testing].
    Hauer B, Seidl K, Senges J.
    Z Kardiol; 1995 Apr 06; 84(4):284-8. PubMed ID: 7785300
    [Abstract] [Full Text] [Related]

  • 13. Determination of the upper limit of vulnerability using implantable cardioverter-defibrillator electrograms.
    Swerdlow C, Shivkumar K, Zhang J.
    Circulation; 2003 Jun 24; 107(24):3028-33. PubMed ID: 12810611
    [Abstract] [Full Text] [Related]

  • 14. Patient-tailored implantable cardioverter defibrillator testing using the upper limit of vulnerability: the TULIP protocol.
    Lemke B, Lawo T, Zarse M, Lubinski A, Kreutzer U, Mueller J, Schuchert A, Mitzenheim S, Danilovic D, Deneke T, Threshold test using Upper Limit during ImPlantation Study Group.
    Europace; 2008 Aug 24; 10(8):907-13. PubMed ID: 18515789
    [Abstract] [Full Text] [Related]

  • 15. [Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator].
    Kühlkamp V, Dörnberger V, Mermi J, Mewis C, Seipel L.
    Z Kardiol; 1996 May 24; 85(5):306-11. PubMed ID: 8711942
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The vulnerable period for low and high energy T-wave shocks: role of dispersion of repolarisation and effect of d-sotalol.
    Kirchhof PF, Fabritz CL, Zabel M, Franz MR.
    Cardiovasc Res; 1996 Jun 24; 31(6):953-62. PubMed ID: 8759252
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of low-energy T wave shocks for induction of ventricular fibrillation in patients with implantable cardioverter defibrillators.
    Bhandari AK, Isber N, Estioko M, Ziccardi T, Cannom DS, Park Y, Lerman RD, Prejean C, Sun GW.
    J Electrocardiol; 1998 Jan 24; 31(1):31-7. PubMed ID: 9533375
    [Abstract] [Full Text] [Related]

  • 19. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
    Adragão P, Parreira L, Neves J, Morgado F, Abecassis M, Almeida M, Martins D, Bonhorst D, Seabra-Gomes R.
    Rev Port Cardiol; 1996 Mar 24; 15(3):195-206, 179, 181. PubMed ID: 8634168
    [Abstract] [Full Text] [Related]

  • 20. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP.
    J Am Coll Cardiol; 2004 Jun 16; 43(12):2293-9. PubMed ID: 15193696
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.